Bidlingmaier C - Search Results

1

Practical Guidance of the GTH Haemophilia Board on the Use of Emicizumab in Patients with Haemophilia A.

Holstein K, Albisetti M, Bidlingmaier C, Halimeh S, Heine S, Klamroth R, Königs C, Kurnik K, Male C, Oldenburg J, Streif W, Wermes C, Escuriola-Ettingshausen C; ‘Ständige Kommission Hämophilie’ (Haemophilia board) of the German, Swiss Austrian Society for Thrombosis Haemostasis Research (GTH). Holstein K, et al. Among authors: bidlingmaier c. Hamostaseologie. 2020 Dec;40(5):561-571. doi: 10.1055/a-1127-6476. Epub 2020 Jun 25. Hamostaseologie. 2020. PMID: 32588417 Review.

2

Haemophilia A in two premature infants.

Bidlingmaier C, Bergmann F, Kurnik K. Bidlingmaier C, et al. Eur J Pediatr. 2005 Feb;164(2):70-2. doi: 10.1007/s00431-004-1542-6. Epub 2004 Dec 3. Eur J Pediatr. 2005. PMID: 15580358

3

Thromboembolism in neonates and infants: impact of underlying diseases, prothrombotic risk factors and treatment modalities.

Kurnik K, Duering C, Bidlingmaier C, Nowak-Göttl U. Kurnik K, et al. Among authors: bidlingmaier c. Thromb Res. 2005 Feb;115 Suppl 1:71-7. Thromb Res. 2005. PMID: 15790161 No abstract available.

4

Safety and efficacy of danaparoid (Orgaran) use in children.

Bidlingmaier C, Magnani HN, Girisch M, Kurnik K. Bidlingmaier C, et al. Acta Haematol. 2006;115(3-4):237-47. doi: 10.1159/000090941. Acta Haematol. 2006. PMID: 16549902

5

Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections.

Bidlingmaier C, Deml MM, Kurnik K. Bidlingmaier C, et al. Haemophilia. 2006 May;12(3):212-7. doi: 10.1111/j.1365-2516.2006.01217.x. Haemophilia. 2006. PMID: 16643203 Clinical Trial.

6

Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children--results of a multicenter studys.

Kurnik K, Kreuz W, Horneff S, Düring C, Schobess R, Bidlingmaier C, Ettingshausen CE, Krümpel A, Bogdanova N, Nowak-Göttl U. Kurnik K, et al. Among authors: bidlingmaier c. Haematologica. 2007 Jul;92(7):982-5. doi: 10.3324/haematol.11161. Haematologica. 2007. PMID: 17606451 Free article.

7

Reconstituting factor concentrates: Defining Evidence of Coaching Non-Experts (DEVICE) in haemophilia--a prospective randomized feasibility study.

Bidlingmaier C, Kurnik K, Hölscher G, Kappler M. Bidlingmaier C, et al. Haemophilia. 2007 Sep;13(5):470-2. doi: 10.1111/j.1365-2516.2007.01439.x. Haemophilia. 2007. PMID: 17880431 Clinical Trial.

8

Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.

Schobess R, Kurnik K, Friedrichs F, Halimeh S, Krümpel A, Bidlingmaier C, Nowak-Göttl U. Schobess R, et al. Among authors: bidlingmaier c. Thromb Haemost. 2008 Jan;99(1):71-6. doi: 10.1160/TH07-06-0417. Thromb Haemost. 2008. PMID: 18217137

9

Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia A.

Wieland I, Wermes C, Eifrig B, Holstein K, Pollmann H, Siegmund B, Bidlingmaier C, Kurnik K, Nimtz-Talaska A, Niekrens C, Eisert R, Tiede A, Ebenebe C, Lakomek M, Hoy L, Welte K, Sykora KW. Wieland I, et al. Among authors: bidlingmaier c. Hamostaseologie. 2008 Oct;28 Suppl 1:S26-8. Hamostaseologie. 2008. PMID: 18958335

10

Haemostatic testing prior to elective surgery in children? Not always!

Bidlingmaier C, Eberl W, Knöfler R, Olivieri M, Kurnik K. Bidlingmaier C, et al. Hamostaseologie. 2009 Jan;29(1):64-7. Hamostaseologie. 2009. PMID: 19151849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page